Hair analysis for cannabinoids and amphetamines in a psychosis incidence study
It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated durin...
Gespeichert in:
Veröffentlicht in: | European neuropsychopharmacology 2002-02, Vol.12 (1), p.27-30 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 30 |
---|---|
container_issue | 1 |
container_start_page | 27 |
container_title | European neuropsychopharmacology |
container_volume | 12 |
creator | Selten, Jean-Paul Bosman, Ingrid J de Boer, Douwe Veen, Natalie D van der Graaf, Yolanda Maes, Robert A.A Kahn, René S |
description | It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method. |
doi_str_mv | 10.1016/S0924-977X(01)00129-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71407642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924977X01001298</els_id><sourcerecordid>71407642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMo7vrxE5ScRA_VfDbtSWRRV1j0oIK3kE1SNtKma9IK_femu4sePQ3MPO8M8wBwhtE1Rji_eUUlYVkpxMclwlcIYVJmxR6Y4kLQTBQ52QfTX2QCjmL8TBCntDwEE4xFURAqpuB5rlyAyqt6iC7Cqg1QK-_V0vnWmZgmBqpmvbKdapy3EToPFVzHQa_aMeC8dsZ6bWHsejOcgINK1dGe7uoxeH-4f5vNs8XL49PsbpFpmuMuM0utqSCC5oibnJOKoYoro41OPa1ZaTg3wlqDCGLpXa0IN6nBGS4Zoogeg4vt3nVov3obO9m4qG1dK2_bPkqBGRI5IwnkW1CHNsZgK7kOrlFhkBjJUaTciJSjJYmw3IiURcqd7w70y8aav9TOXAJut4BNb347G2TUbhRhXLC6k6Z1_5z4AVoLg34</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71407642</pqid></control><display><type>article</type><title>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Selten, Jean-Paul ; Bosman, Ingrid J ; de Boer, Douwe ; Veen, Natalie D ; van der Graaf, Yolanda ; Maes, Robert A.A ; Kahn, René S</creator><creatorcontrib>Selten, Jean-Paul ; Bosman, Ingrid J ; de Boer, Douwe ; Veen, Natalie D ; van der Graaf, Yolanda ; Maes, Robert A.A ; Kahn, René S</creatorcontrib><description>It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method.</description><identifier>ISSN: 0924-977X</identifier><identifier>EISSN: 1873-7862</identifier><identifier>DOI: 10.1016/S0924-977X(01)00129-8</identifier><identifier>PMID: 11788237</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Amphetamine - analysis ; Amphetamines ; Cannabinoids - analysis ; Cannabis ; Confidence Intervals ; Dopamine Agents - analysis ; Epidemiology ; Female ; Gas Chromatography-Mass Spectrometry - methods ; Hair - chemistry ; Hair analysis ; Humans ; Incidence ; Logistic Models ; Male ; Odds Ratio ; Psychotic Disorders - diagnosis ; Psychotic Disorders - epidemiology ; Psychotic Disorders - psychology ; Schizophrenia ; Substance abuse ; Substance Abuse Detection - methods</subject><ispartof>European neuropsychopharmacology, 2002-02, Vol.12 (1), p.27-30</ispartof><rights>2002 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</citedby><cites>FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0924-977X(01)00129-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11788237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Selten, Jean-Paul</creatorcontrib><creatorcontrib>Bosman, Ingrid J</creatorcontrib><creatorcontrib>de Boer, Douwe</creatorcontrib><creatorcontrib>Veen, Natalie D</creatorcontrib><creatorcontrib>van der Graaf, Yolanda</creatorcontrib><creatorcontrib>Maes, Robert A.A</creatorcontrib><creatorcontrib>Kahn, René S</creatorcontrib><title>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</title><title>European neuropsychopharmacology</title><addtitle>Eur Neuropsychopharmacol</addtitle><description>It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method.</description><subject>Adult</subject><subject>Amphetamine - analysis</subject><subject>Amphetamines</subject><subject>Cannabinoids - analysis</subject><subject>Cannabis</subject><subject>Confidence Intervals</subject><subject>Dopamine Agents - analysis</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Gas Chromatography-Mass Spectrometry - methods</subject><subject>Hair - chemistry</subject><subject>Hair analysis</subject><subject>Humans</subject><subject>Incidence</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Odds Ratio</subject><subject>Psychotic Disorders - diagnosis</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Psychotic Disorders - psychology</subject><subject>Schizophrenia</subject><subject>Substance abuse</subject><subject>Substance Abuse Detection - methods</subject><issn>0924-977X</issn><issn>1873-7862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LxDAQhoMo7vrxE5ScRA_VfDbtSWRRV1j0oIK3kE1SNtKma9IK_femu4sePQ3MPO8M8wBwhtE1Rji_eUUlYVkpxMclwlcIYVJmxR6Y4kLQTBQ52QfTX2QCjmL8TBCntDwEE4xFURAqpuB5rlyAyqt6iC7Cqg1QK-_V0vnWmZgmBqpmvbKdapy3EToPFVzHQa_aMeC8dsZ6bWHsejOcgINK1dGe7uoxeH-4f5vNs8XL49PsbpFpmuMuM0utqSCC5oibnJOKoYoro41OPa1ZaTg3wlqDCGLpXa0IN6nBGS4Zoogeg4vt3nVov3obO9m4qG1dK2_bPkqBGRI5IwnkW1CHNsZgK7kOrlFhkBjJUaTciJSjJYmw3IiURcqd7w70y8aav9TOXAJut4BNb347G2TUbhRhXLC6k6Z1_5z4AVoLg34</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>Selten, Jean-Paul</creator><creator>Bosman, Ingrid J</creator><creator>de Boer, Douwe</creator><creator>Veen, Natalie D</creator><creator>van der Graaf, Yolanda</creator><creator>Maes, Robert A.A</creator><creator>Kahn, René S</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020201</creationdate><title>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</title><author>Selten, Jean-Paul ; Bosman, Ingrid J ; de Boer, Douwe ; Veen, Natalie D ; van der Graaf, Yolanda ; Maes, Robert A.A ; Kahn, René S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Amphetamine - analysis</topic><topic>Amphetamines</topic><topic>Cannabinoids - analysis</topic><topic>Cannabis</topic><topic>Confidence Intervals</topic><topic>Dopamine Agents - analysis</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Gas Chromatography-Mass Spectrometry - methods</topic><topic>Hair - chemistry</topic><topic>Hair analysis</topic><topic>Humans</topic><topic>Incidence</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Odds Ratio</topic><topic>Psychotic Disorders - diagnosis</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Psychotic Disorders - psychology</topic><topic>Schizophrenia</topic><topic>Substance abuse</topic><topic>Substance Abuse Detection - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Selten, Jean-Paul</creatorcontrib><creatorcontrib>Bosman, Ingrid J</creatorcontrib><creatorcontrib>de Boer, Douwe</creatorcontrib><creatorcontrib>Veen, Natalie D</creatorcontrib><creatorcontrib>van der Graaf, Yolanda</creatorcontrib><creatorcontrib>Maes, Robert A.A</creatorcontrib><creatorcontrib>Kahn, René S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Selten, Jean-Paul</au><au>Bosman, Ingrid J</au><au>de Boer, Douwe</au><au>Veen, Natalie D</au><au>van der Graaf, Yolanda</au><au>Maes, Robert A.A</au><au>Kahn, René S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</atitle><jtitle>European neuropsychopharmacology</jtitle><addtitle>Eur Neuropsychopharmacol</addtitle><date>2002-02-01</date><risdate>2002</risdate><volume>12</volume><issue>1</issue><spage>27</spage><epage>30</epage><pages>27-30</pages><issn>0924-977X</issn><eissn>1873-7862</eissn><abstract>It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>11788237</pmid><doi>10.1016/S0924-977X(01)00129-8</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0924-977X |
ispartof | European neuropsychopharmacology, 2002-02, Vol.12 (1), p.27-30 |
issn | 0924-977X 1873-7862 |
language | eng |
recordid | cdi_proquest_miscellaneous_71407642 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Amphetamine - analysis Amphetamines Cannabinoids - analysis Cannabis Confidence Intervals Dopamine Agents - analysis Epidemiology Female Gas Chromatography-Mass Spectrometry - methods Hair - chemistry Hair analysis Humans Incidence Logistic Models Male Odds Ratio Psychotic Disorders - diagnosis Psychotic Disorders - epidemiology Psychotic Disorders - psychology Schizophrenia Substance abuse Substance Abuse Detection - methods |
title | Hair analysis for cannabinoids and amphetamines in a psychosis incidence study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A47%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hair%20analysis%20for%20cannabinoids%20and%20amphetamines%20in%20a%20psychosis%20incidence%20study&rft.jtitle=European%20neuropsychopharmacology&rft.au=Selten,%20Jean-Paul&rft.date=2002-02-01&rft.volume=12&rft.issue=1&rft.spage=27&rft.epage=30&rft.pages=27-30&rft.issn=0924-977X&rft.eissn=1873-7862&rft_id=info:doi/10.1016/S0924-977X(01)00129-8&rft_dat=%3Cproquest_cross%3E71407642%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71407642&rft_id=info:pmid/11788237&rft_els_id=S0924977X01001298&rfr_iscdi=true |